Certara's Upcoming Participation in Investor Conferences
Certara, Inc. (Nasdaq: CERT), a worldwide leader in model-informed drug development, has announced its involvement in several key investor conferences. These events represent important opportunities for the company to connect with both current and potential investors, highlighting its dedication to advancing drug development through innovative technologies.
Morgan Stanley 22nd Annual Global Healthcare Conference
Scheduled for Wednesday, September 4, Certara's management team will present at 4:05 p.m. ET during the Morgan Stanley conference. This event is well-regarded for bringing together top healthcare companies, offering valuable insights into market trends and opportunities.
Baird Global Healthcare Conference
Following the Morgan Stanley event, Certara will take part in the Baird Global Healthcare Conference on Wednesday, September 11, at 10:15 a.m. ET. This conference provides another excellent platform for Certara to engage with key stakeholders in the healthcare sector.
Both conferences will feature live webcasts, allowing investors and interested parties to easily access the presentations. These webcasts will be available on Certara’s investor relations website and can be replayed for at least 90 days after the events.
About Certara
Certara accelerates the drug development process by utilizing biosimulation software, advanced technologies, and specialized services. This innovative approach enables the company to transform traditional drug discovery and development methods. Certara caters to a diverse range of clients, including over 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries worldwide.
As a trailblazer in this field, Certara strives to revolutionize the development of new therapeutics through its cutting-edge methodologies and scientific expertise. Their commitment to improving drug development outcomes continues to solidify their position as a leader in the biopharmaceutical industry.
Investor Relations
The company invites interested investors to reach out for further information. Investor relations are managed by David Deuchler from the Gilmartin Group, who is available to respond to inquiries via email at ir@certara.com.
Media Contact
For media inquiries, Alyssa Horowitz is available to provide information regarding Certara’s initiatives and activities. She can be contacted at certara@pancomm.com.
Frequently Asked Questions
What is the purpose of Certara's participation in these conferences?
Certara participates in investor conferences to engage with potential and current investors, share company updates, and provide insights into their business strategies.
When will Certara present at the Morgan Stanley conference?
Certara will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, at 4:05 p.m. ET.
How can investors access the conference presentations?
Investors can access the live webcasts of the presentations on Certara's investor relations website, which will also host replays for at least 90 days after the events.
Who can be contacted for further investor relations inquiries?
David Deuchler from the Gilmartin Group is responsible for investor relations and can be contacted at ir@certara.com.
What technology does Certara use to accelerate drug development?
Certara uses biosimulation software and advanced technologies to enhance and expedite the traditional drug discovery and development processes.
